1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Executive Summary

• 2.1 Report Guide
• 2.2 Methodology
• 2.3 Market Segmentation
• 2.4 Cancer Biomarker Market- Key Findings, 2020

3. Strategic Imperatives on Global Cancer Biomarker Market

• 3.1 COVID-19 Impact Analysis
• 3.2 Market Trends- Across Types, Applications, End User Types, Countries
• 3.3 Insights into Main Market Categories
• 3.4 Market Drivers and Restraints
• 3.5 Growth Opportunities Critical for Future Success
• 3.6 Key Cancer Biomarker Companies

4. Cancer Biomarkers Market Value Outlook to 2026, By Type

• 4.1 Genetic Biomarkers
  • 4.1.1 Lung Cancer
  • 4.1.2 Colorectal Cancer
  • 4.1.3 Breast Cancer
  • 4.1.4 Prostate Cancer
  • 4.1.5 Leukemia
• 4.2 Protein Biomarkers
• 4.3 Other Cancer Biomarkers

5. Cancer Biomarkers Market Value Outlook to 2026, By Technology

• 5.1 Omics Technologies
  • 5.1.1 Proteomics
  • 5.1.2 Genomics
  • 5.1.3 Next-Generation Sequencing
  • 5.1.4 Polymerase Chain Reaction
• 5.2 Imaging Technologies
  • 5.2.1 Ultrasound
  • 5.2.2 Computed Tomography
  • 5.2.3 Magnetic Resonance Imaging
  • 5.2.4 Positron Emission Tomography
  • 5.2.5 Mammography
• 5.3 Immunoassays
• 5.4 Cytogenetics
  • 5.4.1 in Situ Hybridization
  • 5.4.2 Other Cytogenetics-Based Tests
• 5.5 Bioinformatics

6. Cancer Biomarkers Market Value Outlook to 2026, By Application

• 6.1 Diagnostics
• 6.2 Research and Development
• 6.3 Prognostics
• 6.4 Risk Assessment
• 6.5 Other Applications

7 Asia Pacific Cancer Biomarker Market Value Outlook to 2026

• 7.1 Leading Cancer Biomarker Types contributing to Asia Pacific market
• 7.2 Top Applications contributing to Asia Pacific Cancer Biomarker
• 7.3 Top countries contributing to Asia Pacific Cancer Biomarker

8 Europe Cancer Biomarker Market Value Outlook to 2026

• 8.1 Leading Cancer Biomarker Types contributing to Europe market
• 8.2 Top Applications contributing to Europe Cancer Biomarker
• 8.3 Top countries contributing to Europe Cancer Biomarker

9 North America Cancer Biomarker Market Value Outlook to 2026

• 9.1 Leading Cancer Biomarker Types contributing to North America market
• 9.2 Top Applications contributing to North America Cancer Biomarker
• 9.3 Top countries contributing to North America Cancer Biomarker

10 South and Central America Cancer Biomarker Market Value Outlook to 2026

• 10.1 Leading Cancer Biomarker Types contributing to South and Central America market
• 10.2 Top Applications contributing to South and Central America Cancer Biomarker
• 10.3 Top countries contributing to South and Central America Cancer Biomarker

11 Middle East Africa Cancer Biomarker Market Value Outlook to 2026

• 11.1 Leading Cancer Biomarker Types contributing to Middle East Africa market
• 11.2 Top Applications contributing to Middle East Africa Cancer Biomarker
• 11.3 Top countries contributing to Middle East Africa Cancer Biomarker

12 Business Profiles of Leading Companies

• 12.1 Business Description, SWOT and Financial Analysis of Companies in Cancer Biomarker market
• 12.2 Abbott Laboratories
• 12.3 Agilent Technologies
• 12.4 Biomérieux SA
• 12.5 Bio-Rad Laboratories
• 12.6 GE Healthcare
• 12.7 Illumina
• 12.8 Merck & Co.
• 12.9 Qiagen N.V.
• 12.10 Roche Diagnostics
• 12.11 Thermo Fisher Scientific

13 Recent Industry Developments

14 Appendix

• 14.1 OGAnalysis Expertise
• 14.2 Sources and Methodology

The study predicts the short term and long term trends that can shape up the future of the Cancer Biomarker market including the COVID-19 pandemic implications for Cancer Biomarkers industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

The Cancer Biomarker market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. Cancer Biomarker Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. Cancer Biomarker market forecast and Cancer Biomarker market growth is outlook through 2026.

The report reflects on predictions with 2019 as the base year and 2020- 2026 as the forecast period. The research was based on the findings of expert team of analysts analyzing the Cancer Biomarker market opportunities, underlying market factors, demographic and economic factors, market developments and others.

Cancer Biomarker industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening Cancer Biomarker market share in developed countries.

Scope of the research-

Cancer Biomarkers Market is analyzed and forecast over the outlook period from 2020 to 2026 By type including
Genetic Biomarkers
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Leukemia
Protein Biomarkers
Other Cancer Biomarkers

Cancer Biomarkers Market is analyzed and forecast over the outlook period from 2020 to 2026 by technology including
Omics Technologies
Proteomics
Genomics
Next-Generation Sequencing
Polymerase Chain Reaction
Imaging Technologies
Ultrasound
Computed Tomography
Magnetic Resonance Imaging
Positron Emission Tomography
Mammography
Immunoassays
Cytogenetics
in Situ Hybridization
Other Cytogenetics-Based Tests
Bioinformatics

Cancer Biomarkers Market is analyzed and forecast over the outlook period from 2020 to 2026 By application including
Diagnostics
Research and Development
Prognostics
Risk Assessment
Other Applications

Top Companies Operating in Cancer Biomarker market include- Abbott Laboratories  , Agilent Technologies  , Biomérieux SA  , Bio-Rad Laboratories , GE Healthcare  , Illumina  , Merck & Co. , Qiagen N.V.  , 120 Roche Diagnostics  , 121 Thermo Fisher Scientific